142139-60-4

142139-60-4 structure

Name: LAPISTERIDE
Chemical Name: (1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-[2-(4-methoxyphenyl)propan-2-yl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide
CAS Number: 142139-60-4
Molecular Formula: C₂₉H₄₀N₂O₃
Molecular Weight: 464.64000
Catalog: Signaling Pathways Metabolic Enzyme/Protease 5 alpha Reductase
Create Date: 2016-12-14 21:16:44
Modify Date: 2024-09-27 22:23:52
Lapisteride (CS 891) is an orally active 5α-reductase inhibitor. Lapisteride can be used in cancer research[1].

Name	(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-[2-(4-methoxyphenyl)propan-2-yl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide
Synonyms	UNII-T50SJ23G82 Lapisteride CS 891

Description	Lapisteride (CS 891) is an orally active 5α-reductase inhibitor. Lapisteride can be used in cancer research[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Metabolic Enzyme/Protease >> 5 alpha Reductase
References	[1]. Yada S, et al. Solid phase transition of CS-891 enantiotropes during grinding. Int J Pharm. 2003 Apr 14;255(1-2):69-79.